Picture of Carl Zeiss Meditec AG logo

AFX — Carl Zeiss Meditec AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Top of the Street: K+S, Rolls-Royce, Carl Zeiss, Deutsche Boerse, CTS Eventim

A round-up of notable broker activity this morning from Europe's
top-ranked* analysts:
    
    ** Berenberg upgrades the potash and salt miner K+S
 SDFGn.DE  to "buy" from "hold" as it expects recovery in potash
prices and higher demand from Brazil in H2
    ** J.P. Morgan raises aero-engineer Rolls-Royce  RR.L  to
"neutral" from "underweight" on significant price increases and
good cost control as civil aerospace volumes are recovering from
pandemic slump
    ** Deutsche Bank cuts medical technology company Carl Zeiss
 AFXG.DE  to "hold" from "buy" on a "heavy" investment program
announced on Friday which should lead to substantial consensus
earnings downgrades for FY24 and outer years 
    ** UBS cuts German bourse operator Deutsche Boerse
 DB1Gn.DE  to "neutral" from "buy" as it sees M&A remaining an
overhang in the mid-term
    
    INITIATIONS AND REINSTATEMENTS
    ** J.P. Morgan initiates the German ticketing firm CTS
Eventim  EVDG.DE  with "overweight", saying the company is set
to benefit from structural growth opportunities, expecting
demand for concert tickets to outgrow supply
    
    
(*Analyst rankings from Thomson Reuters StarMine. The scale is
from 1-star to 5-star with 5 being the best. Analysts are ranked
on earnings accuracy as well as relative performance of
recommendations over trailing 12-month & 24-month periods.)


 (Reporting by Alberto Chiumento and Matteo Allievi)
 ((Matteo.allievi@thomsonreuters.com))

Recent news on Carl Zeiss Meditec AG

See all news